SAVELLI VINNO

Teaching activities

Completion accademic year: 2020/2021

Course year: 6 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2015/2016
Course year: 2 First cycle degree (DM 270) PHYSIOTHERAPY A.Y. 2019/2020
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2018/2019
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2018/2019
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2017/2018
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2018/2019
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2018/2019

Completion accademic year: 2019/2020

Course year: 2 First cycle degree (DM 270) SPEECH AND LANGUAGE THERAPY A.Y. 2018/2019
Course year: 2 First cycle degree (DM 270) PHYSIOTHERAPY A.Y. 2018/2019
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2017/2018

Research

Latest publications:

  • Petrioli, R., Marrelli, D., Roviello, F., D'Ignazio, A., Torre, P., Chirra, M., et al. (2020). Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer. SURGICAL ONCOLOGY, 32, 2-7. - view more
  • Petrioli, R., Francini, E., Cherri, S., Marrelli, D., Roviello, F., Fiaschi, A.I., et al. (2020). Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer. ANTI-CANCER DRUGS, 31(3), 292-297. - view more
  • Marano, L., Fusario, D., Savelli, V., Verre, L., Neri, A., Marrelli, D., et al. (2020). Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses. BMJ OPEN, 10(2), e033634. - view more
  • Marano, L., Ricci, A., Savelli, V., Verre, L., Di Renzo, L., Biccari, E., et al. (2019). From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model. BMC SURGERY, 19(1), 1-6. - view more
  • Petrioli, R., Chirra, M., Messuti, L., Fiaschi, A.I., Savelli, V., Martellucci, I., et al. (2018). Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy. CLINICAL COLORECTAL CANCER, 17(4), 307-312. - view more